BusinessElite Pharmaceuticals Reports Positive Topline Results from SequestOx™ Pilot StudyBy Nasdaq OMXJan 30, 2018, 1:36 PM UTC
BusinessElite Pharmaceuticals Files ANDA for Oxycodone Hydrochloride Extended ReleaseBy Nasdaq OMXSep 20, 2017, 12:38 PM UTC
BusinessElite Announces New Development and License Agreement with SunGen Pharma LLCBy Nasdaq OMXJul 12, 2017, 12:32 PM UTC
BusinessElite Announces Development and License Agreement with SunGen Pharma LLCBy Nasdaq OMXAug 29, 2016, 12:00 PM UTC
BusinessElite Pharmaceuticals, Inc. Reports Financial Results for the First Quarter of Fiscal Year 2017 and Provides Conference Call InformationBy Nasdaq OMXAug 9, 2016, 8:20 PM UTC
BusinessElite Pharmaceuticals, Inc. to Host Conference Call to Discuss 3rd Quarter 2016 Financial Results on February 10, 2016By Nasdaq OMXFeb 5, 2016, 5:43 PM UTC
